You are here

Home

Biblio

Author [ Title(Desc)] Type Year
Filters: Keyword is Genetic Predisposition to Disease  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Horimoto ARVR, Xue D, Thornton TA, Blue EE.  2021.  Admixture mapping reveals the association between Native American ancestry at 3q13.11 and reduced risk of Alzheimer's disease in Caribbean Hispanics.. Alzheimers Res Ther. 13(1):122.
Fernández MVictoria, Kim JHun, Budde JP, Black K, Medvedeva A, Saef B, Deming Y, Del-Aguila J, Ibañez L, Dube U et al..  2017.  Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.. PLoS Genet. 13(11):e1007045.
Belloy ME, Napolioni V, Han SS, Le Guen Y, Greicius MD.  2020.  Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.. JAMA Neurol. 77(7):849-862.
C
Peloso GM, Beiser AS, Satizabal CL, Xanthakis V, Vasan RS, Pase MP, DeStefano AL, Seshadri S.  2020.  Cardiovascular health, genetic risk, and risk of dementia in the Framingham Heart Study.. Neurology. 95(10):e1341-e1350.
Patel D, Zhang X, Farrell JJ, Chung J, Stein TD, Lunetta KL, Farrer LA.  2021.  Cell-type-specific expression quantitative trait loci associated with Alzheimer disease in blood and brain tissue.. Transl Psychiatry. 11(1):250.
Armstrong NJ, Mather KA, Sargurupremraj M, Knol MJ, Malik R, Satizabal CL, Yanek LR, Wen W, Gudnason VG, Dueker ND et al..  2020.  Common Genetic Variation Indicates Separate Causes for Periventricular and Deep White Matter Hyperintensities.. Stroke. 51(7):2111-2121.
de Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V, Jansen IE, Pedersen NL, Stringa N, Zettergren A, Hernández I et al..  2021.  Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.. Nat Commun. 12(1):3417.
E
Reiman EM, Arboleda-Velasquez JF, Quiroz YT, Huentelman MJ, Beach TG, Caselli RJ, Chen Y, Su Y, Myers AJ, Hardy J et al..  2020.  Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study.. Nat Commun. 11(1):667.
F
Vance E, Murcia JDGonzalez, Miller JB, Staley L, Crane PK, Mukherjee S, Kauwe JSK.  2020.  Failure to detect synergy between variants in transferrin and hemochromatosis and Alzheimer's disease in large cohort.. Neurobiol Aging. 89:142.e9-142.e12.
G
Neuner SM, Tcw J, Goate AM.  2020.  Genetic architecture of Alzheimer's disease.. Neurobiol Dis. 143:104976.
Guerreiro R, Gibbons E, Tábuas-Pereira M, Kun-Rodrigues C, Santo GC, Bras J.  2020.  Genetic architecture of common non-Alzheimer's disease dementias.. Neurobiol Dis. 142:104946.
Peloso GM, Beiser AS, DeStefano AL, Seshadri S.  2018.  Genetic Interaction with Plasma Lipids on Alzheimer's Disease in the Framingham Heart Study.. J Alzheimers Dis. 66(3):1275-1282.
Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A et al..  2019.  Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.. Nat Genet. 51(3):414-430.
Chia R, Sabir MS, Bandres-Ciga S, Saez-Atienzar S, Reynolds RH, Gustavsson E, Walton RL, Ahmed S, Viollet C, Ding J et al..  2021.  Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture.. Nat Genet. 53(3):294-303.
de Vries PS, Sabater-Lleal M, Huffman JE, Marten J, Song C, Pankratz N, Bartz TM, de Haan HG, Delgado GE, Eicher JD et al..  2019.  A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology.. Blood. 133(9):967-977.
Wang H, Bennett DA, De Jager PL, Zhang Q-Y, Zhang H-Y.  2021.  Genome-wide epistasis analysis for Alzheimer's disease and implications for genetic risk prediction.. Alzheimers Res Ther. 13(1):55.
Huan T, Joehanes R, Song C, Peng F, Guo Y, Mendelson M, Yao C, Liu C, Ma J, Richard M et al..  2019.  Genome-wide identification of DNA methylation QTLs in whole blood highlights pathways for cardiovascular disease.. Nat Commun. 10(1):4267.
Kunkle BW, Jaworski J, Barral S, Vardarajan B, Beecham GW, Martin ER, Cantwell LS, Partch A, Bird TD, Raskind WH et al..  2016.  Genome-wide linkage analyses of non-Hispanic white families identify novel loci for familial late-onset Alzheimer's disease.. Alzheimers Dement. 12(1):2-10.
Marioni RE, Harris SE, Zhang Q, McRae AF, Hagenaars SP, W Hill D, Davies G, Ritchie CW, Gale CR, Starr JM et al..  2018.  GWAS on family history of Alzheimer's disease.. Transl Psychiatry. 8(1):99.
I
He Z, Liu L, Wang C, Le Guen Y, Lee J, Gogarten S, Lu F, Montgomery S, Tang H, Silverman EK et al..  2021.  Identification of putative causal loci in whole-genome sequencing data via knockoff statistics.. Nat Commun. 12(1):3152.
Baird DA, Liu JZ, Zheng J, Sieberts SK, Perumal T, Elsworth B, Richardson TG, Chen C-Y, Carrasquillo MM, Allen M et al..  2021.  Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome.. PLoS Genet. 17(1):e1009224.
Amlie-Wolf A, Tang M, Mlynarski EE, Kuksa PP, Valladares O, Katanić Ž, Tsuang D, Brown CD, Schellenberg GD, San Wang L-.  2018.  INFERNO: inferring the molecular mechanisms of noncoding genetic variants.. Nucleic Acids Res. 46(17):8740-8753.
Novikova G, Kapoor M, Tcw J, Abud EM, Efthymiou AG, Chen SX, Cheng H, Fullard JF, Bendl J, Liu Y et al..  2021.  Integration of Alzheimer's disease genetics and myeloid genomics identifies disease risk regulatory elements and genes.. Nat Commun. 12(1):1610.
Andrews SJ, Fulton-Howard B, Goate A.  2020.  Interpretation of risk loci from genome-wide association studies of Alzheimer's disease.. Lancet Neurol. 19(4):326-335.
L
Kirola L, Budde JP, Wang F, Norton J, Morris JC, Cruchaga C, Fernández MVictoria.  2021.  Lack of evidence supporting a role for DPP6 sequence variants in Alzheimer's disease in the European American population.. Acta Neuropathol. 141(4):623-624.

Pages

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer